Live Breaking News & Updates on Michaelk Gibson

Stay updated with breaking news from Michaelk gibson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Adding Immunotherapy, Anti-TIGIT in First Line Boosts OS in Esophageal Cancer

But how much did investigational tiragolumab contribute to efficacy? ....

United States , Vanderbilt University , T Ai Pei , National Taiwan University Hospital , Mike Bassett , Michaelk Gibson , Vanderbilt University Medical Center , Chih Hung Hsu , Taipei City , Gastrointestinal Cancers , Hsuc H ,

Dr Gibson on Addressing Remaining Unmet Needs in GI Cancers

Michael K. Gibson MD, PhD, discusses the importance of addressing unmet needs related to treatment for patients with gastrointestinal cancers.
....

Michaelk Gibson , Yelenay Janjigian , Vanderbilt Health , Vanderbilt Ingram Cancer Center , Memorial Sloan Kettering Cancer Center , Translational Research In Head , Translational Research , Neck Oncology , Onclive Tv , Gastrointestinal Cancer , Gi Cancer ,

Research on Novel Targets and Potential Risk Factors Drives Improvements in the Management of GI Cancers

Gastrointestinal oncology experts discuss current strategies and novel developments in gastrointestinal cancers, the role of intestinal dysbiosis and gastrointestinal carcinogenesis, germline genetic features in appendiceal cancer, and the need for anticipatory, multidisciplinary guidance in clinical practice. ....

United States , Vanderbilt University , Brianc Grieb , Rajiv Agarwal , Kristen Ciombor , Cathy Eng , Michael Lidsky , Michaelk Gibson , Danab Cardin , Davidh Johnson , Mariana Xavier Byndloss , Laura Goff , Sekhar Padmanabhan , Vanderbilt Ingram Cancer Center , Patient Care Center , Memorial Sloan Kettering Cancer Center , Division Of Hematology Oncology , Department Of Surgery , Department Of Medicine , Phasei Program In Gastrointestinal Malignancies , Division Of Surgical Oncology Endocrine Surgery , Safety Monitoring Committee , Gastrointestinal Steering Committee , Vanderbilt Health , Translational Research In Head , Young Adults Program ,

Dr Gibson on Advancements in Biomarker Identification in Gastric/GEJ Adenocarcinoma

Michael K. Gibson MD, PhD, discusses advancements in the identification of key biomarkers for patients with gastric or gastroesophageal junction adenocarcinoma, and the subsequent development of biomarker-driven therapeutics in this disease space.
....

Michaelk Gibson , Vanderbilt Ingram Cancer Center , Translational Research In Head , Vanderbilt Health , Translational Research , Neck Oncology , Onclive Tv , Gastrointestinal Cancer , Biomarker Indentification , Gastric Gej Adenocarcinoma ,

Dr Gibson on Current and Emerging Biomarkers in Gastric/GEJ Adenocarcinoma

Michael K. Gibson MD, PhD, discusses current and emerging biomarkers in the treatment of patients with gastric or gastroesophageal junction adenocarcinoma.
....

Michaelk Gibson , Vanderbilt Health , Vanderbilt Ingram Cancer Center , Translational Research In Head , Translational Research , Neck Oncology , Science Summit , Onclive Tv , Gastrointestinal Cancer ,